Table 1 analysis of production costs linked to the development of different vaccines [10]
From: Vaccine market and production capabilities in the Americas
Costs | Cost range |
|---|---|
Product development | > 500 M USD |
Facilities and Equipment | 50 to 700 M USD |
Direct Labor | Typically, less than 25% of the total manufacturing cost |
Overhead | Up to 45% of the cost of raw materials and labor |
Licensing/Regulatory and commercialization | Simple vaccine: - Evaluation fee of 25 to 100 K, and Annual fees of 4.8 K to 140 K USD Combo or Novel Vaccines: - Evaluation fee of 66.5 to 232.8 K USD, and Annual fees of 8.4 to 250 K USD |